Spatially Resolved Microglia/Macrophages in Recurrent Glioblastomas Overexpress Fatty Acid Metabolism and Phagocytic

Akshitkumar M Mistry1,2, Jonah Daneshmand3, SeonYeong Jamie Seo1

  • 1Department of Neurosurgery, University of Louisville, Louisville, KY 40202, USA.

PubMed
Abstract

Insights

Tumor-associated microglia/macrophages in recurrent glioblastoma (GBM) show increased fatty acid and lipid metabolism gene expression. The lipid metabolism gene PLD3 correlates with survival in GBM patients.

Area of Science:

  • Neuro-oncology
  • Cancer immunology
  • Genomics

Background:

  • Glioblastoma (GBM) tumors feature abundant tumor-associated microglia/macrophages.
  • Understanding treatment-induced changes in these cells is crucial.
  • This study investigates gene expression shifts in microglia/macrophages (Iba1+) between de novo and recurrent GBMs.

Purpose of the Study:

  • To analyze gene expression changes in microglia/macrophages (Iba1+) and glial cells (Gfap+) in de novo versus recurrent GBM.
  • To identify key genes and pathways altered during GBM recurrence.
  • To assess the correlation of differentially expressed genes with patient survival.

Main Methods:

  • NanoString GeoMx® Digital Spatial Transcriptomic Profiling was employed on paired de novo and recurrent GBM samples.
  • Microglia/macrophages (Iba1+) and glial cells (Gfap+) were analyzed.
  • Publicly available datasets were used to evaluate the impact of gene expression on patient survival.

Main Results:

  • Transcriptomic data revealed distinct clustering of Iba1+ and Gfap+ cells.
  • Immune-function genes were upregulated in Iba1+ cells compared to Gfap+ cells.
  • Recurrent GBM samples showed upregulation of phagocytosis and fatty acid/lipid metabolism genes in Iba1+ cells, with PLD3 strongly correlating with survival.

Conclusions:

  • Recurrent GBM microglia/macrophages exhibit overexpression of genes related to fatty acid/lipid metabolism.
  • The gene PLD3 is a potential prognostic marker in GBM.
  • Further research into PLD phospholipases' role in GBM progression is warranted.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...